The farnesyl transferase inhibitor (FTI) lonafarnib improves nuclear morphology in ZMPSTE24-deficient fibroblasts from patients with the progeroid disorder MAD-B.

Zokinvy (lonafarnib) - Eiger

http://www.ncbi.nlm.nih.gov/pubmed/38050983

Daniel P Judge; Kamsi O Odinammadu; Kelsey Tuminelli; Khurts Shilagardi; Leslie B Gordon; Susan Michaelis

Dec 6, 2023